Molecule to Market: Inside the outsourcing space

Biotech briefs

In this special episode of Molecule to Market, we go back inside the global drug development space with previous guests Go van Dam, CEO & Founder at TRACER,  Michelle Duggan, Inward Investment Manager, Invest North East England, Peter Soelkner, Managing Director at Vetter and Ross Burn, Chief Executive at CatSci.

Your host, Raman Sehgal, revisits discussions around trends in the biotech space, from episodes including:

• Physician. Scientist. Entrepreneur.
• The UK’s hidden life science gem
• From Pharmacy to $1B family-owned CDMO
• The opportunistic entrepreneur

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.

Africa’s biotech butterfly

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adrienne Leussa, Director of Ecosystem Partnerships at 54gene.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adrienne, covering:

• How the reality of the health challenges living in Africa as a child drove Adrienne into the drug discovery space.
• A rich insight into the only remaining high growth market globally for pharma companies.
• Learn about the main cities driving drug development growth within Africa and the prospect for more localised manufacturing.
• Life working for one of the leading biotech companies in Africa.
• Living life by curiosity as an ethos to make a lasting impact in the world.

Adrienne is a Biochemist (PhD) with 10+ years of hands-on experience and a plethora of diverse technical skills within the area of drug discovery and development. She has also worked as a lecturer and researcher in top African universities helping inspire a generation of scientists through access to information on the applications of biotechnology.She is fluent in 3 of the most used languages in Africa: Portuguese, French and English, and is ardent about continued learning, cross-culture collaboration, problem solving, customer service and mentoring.Adrienne’s mission is to elevate Africa through high quality, innovative, and credible scientific output for global prosperity.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

The global pharma leader with an eye on societal impact

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Enloe, President and CEO at Societal™ CDMO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering:

• Being at the birth of viral vectors and the-infant gene therapy field in the 90s... but choosing not to be there today. 
• After a career spent all over the world - he shares his pearls of wisdom of what he’s learnt from a lifetime of international business.
• Navigating business confusion and redefining companies from the inside out, while focusing on people and patients.
• Being a humble, humane, empathetic leader that does not take himself too seriously... and makes decisions quickly.
• Uncertainty around the capital markets and what this means to the CDMO space in terms of potential headwinds.

David has over two decades of executive leadership experience in biotechnology, clinical drug development, and GMP manufacturing.He was CEO at Ajinomoto Bio-Pharma Services, CEO at Althea CMO and also served as head of Lonza’s Viral Therapeutics Business Unit, which resulted from Lonza’s acquisition of Vivante GMP Solutions. Prior to that, he spent 14 years with a biotech company, Introgen Therapeutics, and played an integral part in taking the company through a successful IPO in 2020.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

From PhD to Pioneer

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ata Tuna Ciftlik CEO at Lunaphore.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ata, covering:

• Bringing the next generation ‘satellite for tumours’ sequencing tools for immuno oncology and cancer research to drug discovery, and eventually the mainstream.
• Why life science start-ups need data to survive and thrive. And key lessons of entrepreneurship, from theory to reality.
• The avalanche effect - from a 2.5k competition fundraise to $50m in a market on-track to become $10b.
• Unmissable leadership lessons from PhD-start up to global life science business.

Ata Tuna Ciftlik was born in Ankara, Turkey. He received a double-B.Sc in Mathematics and Electronics Engineering from Middle East Technical University (METU) in 2006. He started interdisciplinary research at the interface of Microfluidics and Biology during his MSc studies in METU, where he received thesis of the year 2009 prize.

Next, he obtained interdisciplinary PhD in Biomedical Microfluidic Systems from Swiss Institute of Technology in Lausanne (EPFL) and was awarded internationally known Dimitris N. Chorafas foundation prize in the category of cutting egde technology.After inventing its core technology during his PhD, he has co-founded Lunaphore in 2014.

Lunaphore so far received USD 60 million financing from private and public sources, lead multiple innovation projects in Switzerland and Europe, counts close to 100 people, appeared more than 100 times in national and international media channels, claimed 22 awards and has consistently been selected as one of the best start-ups in the country. Ata Tuna is married, has 2 children and enjoys biking, running and hiking.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Supply chain challenges and trends

In this special one-off episode of Molecule to Market, your host Raman Sehgal embarks on a solo cast to cover some of the major supply chain themes uncovered through Molecule to Market interviews.
The insights were originally delivered live on stage at CPhI North America 2022. Whether you’re a CDMO, CPO, drug sponsor or equipment vendor - this is not to be missed.Your host, Raman, covers:

• 4 main challenges the sector has felt over the last two years 
• 4 solutions we are seeing and that you may want to think about
• 4 trends you need to know for your business

Along with being the host of Molecule to Market, Raman Sehgal is the founder of PE-backed ramarketing, co-founder of Lead Candidate, and best-selling author of The Floundering Founder.Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Chats from CPhI North America

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses the pharmaceutical and biotechnology supply chain live from CPhI North America 2022, with:

• Robert Lee, President at Lubrizol Life Science Health - CDMO Division at The Lubrizol Corporation
• Lauren (Naughton) Hanna, Publisher at Contract Pharma
• Bob Macadangdang, Client Development Manager at Sharp, Contract Pharmaceutical Packaging
• Stephen Houldsworth, VP, Global Head of Platform Management & Marketing - Corden Pharma International
• Claire Robinson, Partnership Manager at Sterling Pharma Solutions

What are the biggest challenges in our space? What are the latest trends? What should you be aware of? Listen and find out what our guests think!

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

The BioPharmGuy

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Wilson, President - BioPharmGuy. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering:

• The humble start-up story and journey of the biopharmguy.
• The pivot that took the website from being a job sharing site to one of the most widely-regarded and used platforms in the biotech world.
• The value of simply focussing on looking after your product as your fundamental market differentiator.
• Poking fun at the sector and being a source of entertainment as well as information.

Adam is the BioPharmGuy. Prior to running BioPharmGuy full-time, he worked as a Process Development Engineer at a public biotech, an FDA Investigator and a Lab Tech in a dermatology research lab at a nonprofit hospital. His various experiences have contributed to his knowledge of the biotech industry which has enabled BioPharmGuy to become the best biotech company directory in existence. He independently created and built BioPharmGuy.com which now receives 40,000+ unique visitors every month.

The website built around a database of information on biotech, pharmaceutical, medical device and life science companies around the world. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed. Your host Raman Sehgal is the author of The Floundering Founder.

Chronicles of Swiss Biotech day

Event season is truly well on its way and where better to start than Swiss Biotech Day, the leading biotechnology conference in Switzerland. Renowned for its innovative biotech start-ups and big pharma companies all in attendance, it was a great chance to meet experts from the life science industry from across Europe. Which is why it should come as no surprise that your host Raman Sehgal brought Molecule to market once more to the event space.

If you loved the ‘Memoir of DCAT 2022’ episode, this is a pod for you as he hit the event space again in style and interviewed some more great guests along the way. Listen to a diverse range of our guests’ thoughts during this event.

• Richard Collins, Managing Director Bio2Business Ltd
• Hanns-Christian Mahler, CEO at ten23 health
• Stefano Console, Founder & Senior Advisor at Oriento SA
• Philippe Tschopp, Head of Business Development CDMO Glatt

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.

From CDMO builder to CDMO creator

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Terry Novak, President & Chief Executive Officer at Salubrent Pharma Solutions. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Terry, covering:

• What he has learnt from 40 years in the pharma, biopharma and contract services space
• The best marketing technique - communicating constantly to your internal audience.
• The wave of orphan drugs that are driving demand for small scale and flexible manufacturing capabilities.
• How a focus on talent is going to make or break companies in the next 3-5 years.

Terry has extensive CDMO C-suite execution experience serving in numerous capacities. Terry has served on the Board of Directors of Pernix Therapeutics Ireland, Percivia LLC, American Red Cross Northern NJ Division, Patheon Puerto Rico, Frontline Pharmaceuticals, Curaxis Pharmaceuticals and is currently on the Board of Directors of Salubrent Pharma Services and Minutemen Life Sciences. Operationally, Terry has served as the CEO of Tedor Pharmaceuticals, COO of Pernix Pharma, President of Norwich Pharmaceuticals, President of Patheon North America, President of Frontline Pharmaceuticals and President of DSM.

During his 40 years in industry, he had built a track record of rapid turn-around success includes achieving consistent double-digit growth in revenues and EBITDA.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Built in Boston, now rebuilding businesses

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Kallelis, Chief Executive Officer at Mikart.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mike, covering:

• Growing up, studying and forging a career in Boston during the volatile biotech boom in Massachusetts.
• His hard-earned 40-years playbook of how to rebuild and revitalise a family owned business by respecting, studying and redirecting efforts.
• An insight into the under the radar but explosively vibrant life science scene in Atlanta, GA
• The role of a mid-market CDMO to drug development companies.
• The phenomenon hitting the North America healthcare market that you need to be aware of as it will impact CDMOs in the small molecule space...

Michael Kallelis has spent his career in public and private life science companies where he has successfully implemented commercial and operational growth strategies. Prior to Mikart, he held several senior roles including president of Exiqon Inc., co-founder and chief operating officer of Boston Biosystems, vice president of business development at KMC Systems, and general manager of several GE Healthcare businesses. 

His experience covers a range of technologies, including radiopharmaceuticals, gene expression analysis, medical devices, automated laboratory systems, oligonucleotides, specialty chemicals, biologics, and small molecules. Mike has been the CEO at Mikart since the fall of 2018.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.